Efficacy of a topical product containing purified omental lipids and three anti-itching compounds in the treatment of chronic pruritus/ prurigo nodularis in elderly subjects: A prospective, assessor-blinded, 4-week trial with transepidermal water loss and optical coherence tomography assessments

Marco Ardigò, Chiara Franceschini, Elena Campione, Terenzio Cosio, Caterina Lanna, Luca Bianchi, Massimo Milani

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To investigate the efficacy of a cream containing purified omental lipids 10% and three anti-itching substances (polidocanol/stimutex/palmitoylethanolamine) in elderly subjects with chronic pruritus/prurigo nodularis (CP/CPN). Patients and Methods: Thirty-five subjects (6 men; mean age 67±4 years) with CP/CPN were enrolled in a prospective, assessor-blinded, 4-week study. The cream was applied twice daily in the most affected body area. The primary endpoints were the evolution of the 10-cm visual analogue itch severity scale (VAS) and the 4-point verbal itching rating scale (VRS) (from 0 to 3). Secondary endpoints were the evolution of optical coherence tomography (OTC) of four skin parameters (acanthosis/hyperkeratosis/scale/dermal vascular pattern), assessed in a target lesioned area, and the transepidermal water loss (TEWL). Study end-points were evaluated at baseline and after 2 and 4 weeks by an investigator unaware of the type of treatment. Results: All the enrolled subjects concluded the trial. At baseline, the mean±SD scores for VAS and VRS were 4.9±2.2 and 1.7±0.7, respectively. The treatment was associated with a significant reduction (p=0.0001) of VAS score of 60% at week 2 and of 86% at week 4. VRS score was significantly reduced by 49% after 2 weeks and by 81% after 4 weeks, in comparison with baseline. TEWL (expressed as g/m2/h) mean values were 18±5.4 at baseline and 12.7±4.4 at week 2 and 9.8±4.7 at week 4 (P=0.0001 vs baseline). All the OCT parameters evaluated improved during active treatment; acantho-sis grade was 0.22 mm at baseline, 0.19 mm at week 2 and 0.17 mm at week 4 (p=0.0005), representing a 23% reduction in comparison with baseline. The product was very well tolerated. Conclusion: This purified omental lipid with three anti-itching components cream reduces significantly itch intensity in subjects with chronic pruritus/prurigo nodularis, improving the skin barrier function and skin structure.

Original languageEnglish
Pages (from-to)1051-1058
Number of pages8
JournalClinical, Cosmetic and Investigational Dermatology
Volume13
DOIs
Publication statusPublished - 2020

Keywords

  • Antipruritic
  • Chronic pruritus
  • Itch
  • Prurigo nodularis
  • Purified omental lipids

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Efficacy of a topical product containing purified omental lipids and three anti-itching compounds in the treatment of chronic pruritus/ prurigo nodularis in elderly subjects: A prospective, assessor-blinded, 4-week trial with transepidermal water loss and optical coherence tomography assessments'. Together they form a unique fingerprint.

Cite this